Reporting of immune checkpoint inhibitor-associated myocarditis

Lancet. 2018 Aug 4;392(10145):382-383. doi: 10.1016/S0140-6736(18)31542-3.

Authors

Sadeer G Al-Kindi¹, Guilherme H Oliveira²

Affiliations

¹ Cardio-oncology Program, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
² Cardio-oncology Program, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA. Electronic address: guilherme.oliveira@uhhospitals.org.

PMID: 30102167
DOI: 10.1016/S0140-6736(18)31542-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal
Humans
Myocarditis*
Programmed Cell Death 1 Receptor*

Substances

Antibodies, Monoclonal
Programmed Cell Death 1 Receptor